Special fat formula for babies after biliary atresia surgery
Part of Digestive system, Genetic & congenital clinical trials.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be diagnosed with biliary atresia
- Your baby must have already had the Kasai procedure
- Your baby must be under 3 months old
- Your baby should not have cirrhosis, hepatitis, or other significant liver diseases
- Your baby should not have other serious whole-body conditions (like major birth defects or chromosome problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
This study tests whether giving umbilical cord stem cells during early Kasai surgery (a procedure to help drain bile) improves outcomes for infants with biliary atresia. It may help your baby's liver function and overall health.
This study tests whether a medicine called NAC (an antioxidant that helps protect the liver) can be safely given to infants with biliary atresia by mouth. It aims to see if babies can tolerate it, which might eventually help their liver health.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.